Preprint · 2026 · Open access
ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation
bioRxiv (Cold Spring Harbor Laboratory) · Published 13 June 2026 · DOI 10.64898/2026.06.13.732026
In brief
“ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation” is a 2026 preprint by Divya N. Nair and 12 co-authors, published in bioRxiv (Cold Spring Harbor Laboratory). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at bioRxiv (Cold Spring Harbor Laboratory).
- Citations
- 0
- References
- 33
- Authors
- 13
Abstract
ONTOSIGHT ® ADMETron is a high-performance SaaS based AI platform designed for the rapid profiling and visualization of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties. The platform integrates a highly interactive web interface with a robust predictive engine, enabling the batch processing of compounds for high-throughput virtual screening. The core engine employs an ensemble model that combines recurrent neural network (RNN)-derived embeddings from SMILES strings with physicochemical descriptors, which are fed into gradient boosting machines (GBMs). This architecture provides accurate predictions across 34 distinct ADMET endpoints, encompassing critical categories such as physicochemical properties, absorption, CYP450 inhibition, hERG toxicity, and mutagenicity. The platform’s superior performance is quantitatively validated by its top-tier ranking on the Therapeutics Data Commons (TDC) ADMET Benchmark Group, demonstrating robustness and generalizability with notable results including 2nd place for Ames mutagenicity (AUROC 0.870) and 2nd place for LD50 (MAE 0.573). In addition to its predictive capabilities, ADMETron introduces a novel SAR analysis framework that enables real-time comparison of multiple compounds and approved drugs through an interactive radar graph visualization. Comparative evaluation against widely used online ADMET platforms demonstrated broader endpoint coverage, including pharmacokinetic, physicochemical, and medicinal chemistry assessments within a unified environment. The combination of benchmark-validated predictive performance, comprehensive ADMET profiling, and advanced visualization tools positions ADMETron as a next-generation platform for virtual screening, lead optimization, and data-driven decision-making in modern drug discovery ( https://admetron.partex.ai/ ).
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nair, D. N., Yadav, R. S., Jondhale, P. M., Didhate, S., Gunjal, G., Ranjit, A., Patil, P., Dawande, A., Shisode, A., Bhagwat, A., Scheele, J., Zharavin, V., & Arora, S. (2026). ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.64898/2026.06.13.732026
MLA 9
Nair, Divya N., et al. “ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation.” bioRxiv (Cold Spring Harbor Laboratory), 2026. https://doi.org/10.64898/2026.06.13.732026.
Chicago
Nair, Divya N., Rohit Singh Yadav, Prajakta Mate Jondhale, Sumit Didhate, Gayatri Gunjal, Aryaman Ranjit, Prashant Patil, et al. 2026. “ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation.” bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.64898/2026.06.13.732026.
Harvard
Nair, D. N. et al. (2026) ‘ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation’, bioRxiv (Cold Spring Harbor Laboratory). doi:10.64898/2026.06.13.732026.
IEEE
D. N. Nair et al., “ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation,” bioRxiv (Cold Spring Harbor Laboratory), 2026, doi: 10.64898/2026.06.13.732026.
BibTeX
@misc{nair2026admetron,
title = {{ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation}},
author = {Nair, Divya N. and Yadav, Rohit Singh and Jondhale, Prajakta Mate and Didhate, Sumit and Gunjal, Gayatri and Ranjit, Aryaman and Patil, Prashant and Dawande, Atish and Shisode, Ashishkumar and Bhagwat, Ameya and Scheele, Juergen and Zharavin, Victor and Arora, Sahil},
howpublished = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2026},
doi = {10.64898/2026.06.13.732026},
url = {https://doi.org/10.64898/2026.06.13.732026}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- ADMET prediction
- SaaS platform
- virtual screening
- ensemble learning
- SMILES
- gradient boosting
- cytochrome P450 inhibition
- mutagenicity
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Nair, D. N., Yadav, R. S., Jondhale, P. M., Didhate, S., Gunjal, G., Ranjit, A., Patil, P., Dawande, A., Shisode, A., Bhagwat, A., Scheele, J., Zharavin, V., & Arora, S. (2026). ADMETron: An AI-driven SaaS platform for comprehensive ADMET prediction and compound prioritisation. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.64898/2026.06.13.732026
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at bioRxiv (Cold Spring Harbor Laboratory).
Who wrote this paper?
Divya N. Nair, Rohit Singh Yadav, Prajakta Mate Jondhale, Sumit Didhate, Gayatri Gunjal, Aryaman Ranjit, Prashant Patil, Atish Dawande, Ashishkumar Shisode, Ameya Bhagwat, Juergen Scheele, Victor Zharavin and 1 more.
What is the DOI of this paper?
10.64898/2026.06.13.732026. The permanent link is https://doi.org/10.64898/2026.06.13.732026.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.